Patents by Inventor Holger J. Moller

Holger J. Moller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD163-binding conjugates
    Patent number: 9476890
    Abstract: The present invention relates to haptoglobin-haemoglobin (Hp-Hb) complex or a part thereof or a mimic thereof being operably linked to a substance and capable of binding a CD163 receptor. Furthermore, the invention relates to a CD163 variant, membrane bound or soluble, capable of binding at least one haptoglobin-haemoglobin (Hp-Hb) complex, and the use of the Hp-Hb complex and the CD163 receptor for therapy.
    Type: Grant
    Filed: November 20, 2007
    Date of Patent: October 25, 2016
    Assignee: AFFINICON APS
    Inventors: Soren Moestrup, Holger J. Moller
  • METHOD OF PROGNOSIS
    Publication number: 20150093765
    Abstract: The present invention relates to the use of soluble CD163 as a prognostic marker for the assessment of the risk for contracting a disorder, in particular for contracting diabetes and/or a liver disorder. The invention also relates to the use of CD163 as a prognostic marker for assessing lifetime expectancy.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 2, 2015
    Inventors: Søren Moestrup, Ruth Frikke-Schmidt, Anne Tybjaerg-Hansen, Holger J. Moller
  • METHOD OF PROGNOSIS
    Publication number: 20120252041
    Abstract: The present invention relates to the use of soluble CD163 as a prognostic marker for the assessment of the risk for contracting a disorder, in particular for contracting diabetes and/or a liver disorder. The invention also relates to the use of CD163 as a prognostic marker for assessing lifetime expectancy.
    Type: Application
    Filed: October 12, 2010
    Publication date: October 4, 2012
    Applicants: Region Midjylland, Aarhus Universitet
    Inventors: Søren Moestrup, Ruth Frikke-Schmidt, Anne Tybjaerg-Hansen, Holger J. Møller
  • FUNCTION OF A HAPTOGLOBIN-HAEMOGLOBIN RECEPTOR AND THE USES THEREOF
    Publication number: 20080242843
    Abstract: The present invention relates to haptoglobin-haemoglobin (Hp-Hb) complex or a part thereof or a mimic thereof being operably linked to a substance and capable of binding a CD163 receptor. Furthermore, the invention relates to a CD163 variant, membrane bound or soluble, capable of binding at least one haptoglobin-haemoglobin (Hp-Hb) complex, and the use of the Hp-Hb complex and the CD163 receptor for therapy.
    Type: Application
    Filed: November 20, 2007
    Publication date: October 2, 2008
    Inventors: Soren Moestrup, Holger J. Moller
  • Function of a haptoglobin-haemoglobin receptor and the uses thereof
    Publication number: 20020155995
    Abstract: The present invention relates to haptoglobin-haemoglobin (Hp-Hb) complex or a part thereof or a mimic thereof being operably linked to a substance and capable of binding a CD163 receptor. Furthermore, the invention relates to a CD163 variant, membrane bound or soluble, capable of binding at least one haptoglobin-haemoglobin (Hp-Hb) complex, and the use of the Hp-Hb complex and the CD163 receptor for therapy.
    Type: Application
    Filed: October 16, 2001
    Publication date: October 24, 2002
    Applicant: ProteoPharma ApS
    Inventors: Soren Moestrup, Holger J. Moller